BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9620710)

  • 41. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.
    Agarwal P; Sander GE; Giles TD
    Am J Geriatr Cardiol; 2004; 13(6):332-5. PubMed ID: 15538074
    [No Abstract]   [Full Text] [Related]  

  • 42. At the heart of the matter: sex.
    SoRelle R
    Circulation; 1999 Nov; 100(21):e102-3. PubMed ID: 10571982
    [No Abstract]   [Full Text] [Related]  

  • 43. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
    Shabsigh R; Seftel AD; Rosen RC; Porst H; Ahuja S; Deeley MC; Garcia CS; Giuliano F
    Urology; 2006 Oct; 68(4):689-96. PubMed ID: 17070333
    [No Abstract]   [Full Text] [Related]  

  • 44. My insurance company won't pay for my prescription for Viagra without a letter from my doctor saying that I have been evaluated. As far as I know, I am the only one who can tell whether I have impotence. What does the insurance company want?
    Lee TH
    Harv Heart Lett; 1999 Mar; 9(7):7. PubMed ID: 10066324
    [No Abstract]   [Full Text] [Related]  

  • 45. Sildenafil citrate for the management of antidepressant-associated erectile dysfunction.
    Nurnberg HG; Hensley PL
    J Clin Psychiatry; 2003; 64 Suppl 10():20-5. PubMed ID: 12971812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of sildenafil for patients with penile hypotonia.
    Vasudevan D
    Am Fam Physician; 2003 Mar; 67(6):1195. PubMed ID: 12674449
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sildenafil--adverse effects, complications and safety].
    Sperling H; Michel MC
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):4-6. PubMed ID: 12407928
    [No Abstract]   [Full Text] [Related]  

  • 49. Ophthalmic aspects of erectile dysfunction drugs.
    Verit A; Oguz H
    Am J Ophthalmol; 2006 Mar; 141(3):598; author reply 599. PubMed ID: 16490529
    [No Abstract]   [Full Text] [Related]  

  • 50. Tachyphylaxis and phosphodiesterase type 5 inhibitors.
    Steers WD
    J Urol; 2002 Jul; 168(1):207. PubMed ID: 12050542
    [No Abstract]   [Full Text] [Related]  

  • 51. [Sildenafil].
    Wespes E; Sternon J; Hirsch E; Schulman C
    Rev Med Brux; 1998 Oct; 19(5 Pt 1):437-41. PubMed ID: 9844484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sildenafil citrate-associated priapism.
    Sur RL; Kane CJ
    Urology; 2000 Jun; 55(6):950. PubMed ID: 10840123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rates of non-arteritic ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.
    Tsertsvadze A
    Am J Ophthalmol; 2009 Oct; 148(4):625; author reply 625-6. PubMed ID: 19782802
    [No Abstract]   [Full Text] [Related]  

  • 54. Optic atrophy after sildenafil use.
    Duszak R; Verghese M; Rinehart C; Alexander A
    Optometry; 2007 Jul; 78(7):329; author reply 329-30. PubMed ID: 17601569
    [No Abstract]   [Full Text] [Related]  

  • 55. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U; Gleiter CH
    Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Male sexual dysfunction involving penile erection, emission and ejaculation].
    Shiina H; Igawa M
    Nihon Rinsho; 2006 Jun; Suppl 2():279-83. PubMed ID: 16817403
    [No Abstract]   [Full Text] [Related]  

  • 57. Viagra! Are we ready?
    Evans MF
    Can Fam Physician; 1998 Oct; 44():2103-5. PubMed ID: 9805164
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute angle-closure glaucoma following sildenafil citrate-aided sexual intercourse.
    Ramasamy B; Rowe F; Nayak H; Peckar C; Noonan C
    Acta Ophthalmol Scand; 2007 Mar; 85(2):229-30. PubMed ID: 17305747
    [No Abstract]   [Full Text] [Related]  

  • 59. Sildenafil in pulmonary hypertension.
    Nanivadekar A
    Indian Heart J; 2003; 55(3):285; author reply 285. PubMed ID: 14560947
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.